II. Class

  1. Rifamycin
    1. Inhibits Bacterial RNA Polymerase

III. Mechanism

  1. Long-acting Rifampin derivative

IV. Indications

V. Contraindications

  1. Children under age 2 years
  2. Latent Tuberculosis with suspected resistance to Isoniazid or Rifampin
  3. HIV patients on Antiretrovirals (due to lower drug levels and risk of resistance)
  4. Unknown safety in pregnancy

VI. Dosing

  1. Tuberculosis
    1. Part of multi-drug regimen; high risk of drug resistance Tb if used alone
    2. Rifapentine 600 mg orally twice weekly for 2 months then once weekly for 4 months
  2. Latent Tuberculosis
    1. See Latent Tuberculosis

VII. Adverse Effects

  1. See Rifampin
  2. Hyperuricemia
  3. Body secretion discoloration (orange to brown)
    1. Discolors urine and Contact Lenses
  4. Hepatotoxicity (uncommon)
  5. Thrombocytopenia
  6. Neutropenia (rare)

VIII. Drug Interactions

  1. See Rifampin
  2. Metabolized by Cytochrome P-450 3A3/4

IX. Monitoring

  1. Baseline Liver Function Tests and clinical evaluations

Images: Related links to external sites (from Bing)

Related Studies

Ontology: rifapentine (C0073372)

Definition (NCI) A long-acting, cyclopentyl-substituted derivative of rifamycin used to treat mycobacterium infections.
Concepts Antibiotic (T195) , Organic Chemical (T109)
MSH C018421
SnomedCT 108686006, 410831004
English 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)rifamycin, 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)rifamycin SV, rifapentine, rifapentine (medication), rifapentine [Chemical/Ingredient], Rifapentine (substance), Rifapentine, Rifapentine (product), RIFAPENTINE
Spanish rifapentina (sustancia), rifapentina, rifapentina (producto)

Ontology: Priftin (C0876758)

Concepts Antibiotic (T195) , Organic Chemical (T109)
MSH C018421
English Priftin, Aventis Behring brand of rifapentine